MAYSAE SANCROWN: Open Payments
NPI 1407110919 · UTICA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$479 in 22 payments from 8 companies in 2025. Trend: 2023 $681 · 2024 $736 · 2025 $479
Food & beverage: $479
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $145 |
| GlaxoSmithKline, LLC. | 4 | $85 |
| Lilly USA, LLC | 4 | $81 |
| PFIZER INC. | 4 | $75 |
| Novo Nordisk Inc | 2 | $36 |
| Gilead Sciences, Inc. | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $14 |
Products named: BREZTRI, TRELEGY ELLIPTA, MOUNJARO, JARDIANCE, ELIQUIS, SHINGRIX, AIRSUPRA, Ozempic.
Industry payments across NY — which companies pay providers there.
